Pharmaceuticals - Community Register


Community list of not active medicinal products for human use


Product information

Invented name: EchoGen
Auth. number : EU/1/98/072
Active substance : Dodecafluoropentane
ATC: Anatomical main group: V - Various
Therapeutic subgroup: V08 - Contrast media
Pharmacological subgroup: V08D - Ultrasound contrast media
Chemical subgroup: V08DA - Ultrasound contrast media
Chemical substance: V08DA - Ultrasound contrast media
(See WHO ATC Index)
Indication: Transpulmonary echocardiographic contrast agent
Marketing Authorisation Holder: Sonus Pharmaceuticals Ltd
Knyvett House, the Causeway, Staines, Middlesex TW18 3BA, United Kingdom
EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
20/07/1998 Centralised - Authorisation EMEA/H/C/149 (1998)2041 of 17/07/1998
27/01/1999 Centralised - Variation (no change in Commission Decision) EMEA/H/C/149/II/2
09/04/1999 Centralised - Variation EMEA/H/C/149/II/1 (1999)879 of 29/03/1999
13/07/1999 Centralised - Variation (no change in Commission Decision) EMEA/H/C/149/I/4
01/12/1999 Centralised - Variation (no change in Commission Decision) EMEA/H/C/149/II/5
22/03/2000 Centralised - Variation EMEA/H/C/149/I/6 (2000)603 of 09/03/2000
24/01/2001 Centralised - Withdrawal (2001)83 of 22/01/2001